高压球囊治疗动静脉内瘘狭窄的疗效:一项Meta分析
该Meta分析纳入7项研究共364例患者,比较高压球囊(HPB)与常规球囊(CB)治疗动静脉内瘘(AVF)狭窄的疗效。结果显示HPB组术后3个月和6个月再狭窄率显著低于CB组,技术成功率更高,但12个月通畅率两组无显著差异。
要点
- HPB组术后3个月再狭窄率显著低于CB组(OR=0.32,95%CI 0.16~0.61,p<0.001)。
- HPB组术后6个月再狭窄率显著低于CB组(OR=0.29,95%CI 0.11~0.79,p=0.01)。
- HPB组技术成功率高于CB组(OR=0.13,95%CI 0.05~0.36,p<0.001),12个月再狭窄率两组无显著差异。
核心结论
- 高压球囊是治疗AVF狭窄的一种潜在选择,其3个月和6个月再狭窄率低于常规球囊,但12个月通畅率并不优于常规球囊。
- 作者认为应进一步研究球囊扩张术后再狭窄的机制。
研究设计与样本
- Meta分析,检索PubMed、EMBASE、Cochrane Library、SinoMed、CNKI、WanFang和VIP数据库自建库至2020年12月的数据。
- 纳入7项研究共364例患者,所有分析均包含HPB和CB亚组。
- 比较两组术后3、6、12个月AVF通畅率。
主要发现
- HPB组术后3个月再狭窄率显著低于CB组(OR=0.32,95%CI 0.16~0.61,p<0.001)。
- HPB组术后6个月再狭窄率显著低于CB组(OR=0.29,95%CI 0.11~0.79,p=0.01)。
- HPB组技术成功率高于CB组(OR=0.13,95%CI 0.05~0.36,p<0.001)。
- 术后12个月HPB组与CB组再狭窄率无显著差异(OR=0.68,95%CI 0.30~1.52,p=0.35)。
- 分析中未观察到显著发表偏倚。
临床怎么用
- 原文结论指出高压球囊是治疗AVF狭窄的一种潜在选择,其3个月和6个月再狭窄率低于常规球囊。
- 原文结论指出高压球囊12个月通畅率并不优于常规球囊。
- 作者认为应进一步研究球囊扩张术后再狭窄的机制。
局限性
- 作者在结论中提出应进一步研究球囊扩张术后再狭窄的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the present study was to compare the effectiveness of high-pressure balloon (HPB) versus conventional balloon (CB) angioplasty in treating arteriovenous fistula (AVF) stenosis. MATERIALS AND METHODS: A meta-analysis was conducted using data acquired from PubMed, EMBASE, the Cochrane Library, SinoMed, CNKI, WanFang, and VIP databases from the time the databases were established to December 2020. All analyses included in the studies comprised the subgroups of HPB and CB. The patency rates of AVF were compared between 2 groups at 3, 6, and 12 months after operation. RESULTS: Seven studies comprising 364 patients were included in the meta-analyses. The pooled results revealed that restenosis rate of AVFs treated with HPB was significantly lower than that of AVFs treated with CB at 3 months (odds ratio [OR] = 0.32, 95% confidence interval [CI] = 0.16 to 0.61, p<0.001) and 6 months after operation (OR= 0.29, 95% CI = 0.11 to 0.79, p = 0.01). In addition, the technical success rate of HPB groups was higher (OR = 0.13, 95% CI = 0.05 to 0.36, p<0.001). However, no significant difference was observed between HPB and CB groups at 12 months after operation (OR = 0.68, 95% CI = 0.30 to 1.52, p = 0.35). No significant publication bias was observed in the analyses. CONCLUSION: High-pressure balloon is a potential option for the treatment of AVF stenosis, with a lower 3- and 6-month restenosis rate than CB. However, 12-month patency rate of HPB was not superior to CB. Therefore, further studies should be conducted to investigate the mechanisms of restenosis after angioplasty.
引用
- Li Y, Cui W, Wang J, et al. Efficacy of High-Pressure Balloon for the Treatment of Arteriovenous Fistula Stenosis: A Meta-Analysis. J Endovasc Ther. 2021. PMID: 34854339. doi:10.1177/15266028211058690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。